PharmaShots | Incisive News in 3 Shots

Subscribe Now

Exon 53 Skipping Therapy

NS Phrama's Viltepso (viltolarsen) Receives the US FDA's Approval for Patients with Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping Therapy

NS Phrama's Viltepso (viltolarsen) Receives the US FDA's Approval for Patients with Duchenne Muscular Dystrophy Amenable to Exon 5...

August 12, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us